Literature DB >> 11913671

Cardiovascular effects of antipsychotics used in bipolar illness.

Robert W Piepho1.   

Abstract

Many antipsychotics are used to treat disorders other than schizophrenia, such as bipolar disorder. However, some of these agents are associated with cardiovascular side effects that can have serious or fatal implications for the patient. One dangerous side effect is QT prolongation, which can lead to torsades de pointes and ventricular arrhythmia. The group of drugs labeled as antipsychotics is diverse, making it challenging for the clinician to keep track of which agents cause which effects and important for the clinician to learn to identify signs of cardiovascular side effects and manage those events when they occur.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11913671

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  5 in total

1.  QTc Prolongation and the Use of Antipsychotics: A Case Discussion.

Authors:  Jeff C. Huffman; Theodore A. Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-12

2.  A Comparative Study between Olanzapine and Risperidone Regarding Drug-Induced Electrocardiographic Changes.

Authors:  Saeed Shoja Shafti; Parisa Fallah Jahromi
Journal:  Cardiovasc Psychiatry Neurol       Date:  2014-09-09

3.  QT and QTc in Male Patients with Psychotic Disorders Treated with Atypical Neuroleptics.

Authors:  Mario Miniati; Marly Simoncini; Federica Vanelli; Caterina Franceschini; Gabriele Massimetti; Claudia Carmassi; Liliana Dell'Osso
Journal:  ScientificWorldJournal       Date:  2017-07-12

4.  Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities.

Authors:  Kimberly D McLaren; Lauren B Marangell
Journal:  Ann Gen Hosp Psychiatry       Date:  2004-04-22

5.  Antipsychotic Medication and QT Prolongation.

Authors:  Paramdip Singh Chohan; Raman Mittal; Afzal Javed
Journal:  Pak J Med Sci       Date:  2015 Sep-Oct       Impact factor: 1.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.